Here are five points:
1. Two of the patents focus on presacral interbody fusion, specifically two new expandable cages.
2. The expandable cages are intended to create lordosis at L5-S1.
3. The third patent relates to a new technique designed for sacroiliac fusion.
4. TranS1 possesses a portfolio of minimally invasive spine surgery solutions as well as a patent portfolio of spinal health technologies.
5. Over the past three years, the company has received 100-plus issued patents and has 50-plus new patent applications.
More articles on MIS:
Titan Medical reports 2017 full-year financial results: 5 things to know
Saint Anne’s Hospital launches Globus ExcelsiusGPS for minimally invasive spine surgery: 3 insights
7 top device companies in global minimally invasive spine surgery market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
